In Other News

• DNA Methylation May Predict Treatment Response in Myelodysplastic Syndromes

• Antibody Testing Informs Melioidosis Diagnosis and Surveillance in Emerging Regions

• Gastrointestinal Flex Assay Gains EU Certification for Tailored Pathogen Testing

• Circulating Tumor DNA Test Identifies Complete Immunotherapy Responders

• Combined Blood and Imaging Data Help Identify More Lung Cancer Cases

• Antibody Testing Informs Melioidosis Diagnosis and Surveillance in Emerging Regions

• Extracellular Vesicle Biomarkers Reveal Shared Signals in Aging and Cancer

• Molecular Panels Gain FDA Clearance for One-Hour Gastrointestinal Pathogen Testing

• Routine Opt-Out Screening Helps Increase Detection of Adolescent STIs

• Blood Protein Panel Detects ALS with High Accuracy

• Multiplexed Single-Cell DNA Methylation Workflow Enables Analysis of Blood Disorders

• Common Genetic Variant Increases Risk of Bacterial Pneumonia

• Study Reveals Regulatory DNA Element Involved in Breast Cancer Growth Suppression

• New Research Examines Hi-C Sequencing Across Solid Tumors and Lymphoma

• Single-Vesicle Analysis Reveals Tissue-Associated Inflammatory Signatures

• Plasma Proteomic Test Detects Immunotherapy Resistance Before Imaging in Lung Cancer

• Routine Opt-Out Screening Helps Increase Detection of Adolescent STIs

• Siemens Healthineers Begins Transition Toward Standalone Olyrian Diagnostics Business

• Comprehensive Tumor Profiling Uncovers Overlooked Hereditary Cancer Risk Genes

• Nonendoscopic Methylation Assay Enables Rapid Barrett’s Esophagus Screening

• New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients

• Studies Support MRD Testing to Detect Head and Neck Cancer Recurrence

• New qPCR Master Mixes Offer Broad Compatibility for Routine Research